home / stock / pmcb / pmcb news

PMCB News and Press, PharmaCyte Biotech Inc. From 12/10/19

Stock Information
Company Name: PharmaCyte Biotech Inc.
Stock Symbol: PMCB
Market: OTC
Website: pharmacyte.com
Menu
PMCB PMCB Quote PMCB Short PMCB News PMCB Articles PMCB Message Board
Get PMCB Alerts

News, Short Squeeze, Breakout and More Instantly...
PMCB - PharmaCyte Biotech to Hold Quarterly Shareholder Update

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that its quarterly shareholder update will be held on December 20, 20...
PMCB - PharmaCyte Biotech "Release Testing" Successful on All Completed Tests of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today an update on the completed tests that are part of the U.S. Food and D...

PMCB - PharmaCyte Biotech Successfully Completes Final Manufacturing Run of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that its partner, Austrianova Singapore (Austrianova), has successful...

PMCB - PharmaCyte Biotech's "Release Testing" Last Critical Event Before Submission of Investigational New Drug Application

NEW YORK, NY, Nov. 12, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has reduced a long list of FDA-required items to just one last important component—release testing—before it can submit an Investigational New Drug application (IND) to the U.S. FDA.  PharmaC...
PMCB - PharmaCyte Biotech Closer to Submitting IND by Successfully Completing Encapsulation of Second Manufacturing Run of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , is closer to submitting an Investigational New Drug application (IND) to the U.S. Foo...

PMCB - PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology in Pancreatic Cancer Trial

NEW YORK, NY, Oct. 28, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has a technology that could very well change the way a host of hard-to-treat diseases are treated for the foreseeable future.  The company is closer than ever to its upcoming Phase 2b clinical trial in loc...

PMCB - PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product

NEW YORK, NY, Oct. 16, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has now moved one step closer to submitting an Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) to request a clinical trial in locally advanced, inoperable pancreatic ca...
PMCB - PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that its partner, Austrianova Singapore (Austrianova), has completed ...

PMCB - PharmaCyte Biotech Q&A Discussion with Cellular Biologist David A. Judd

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today the latest in its series of Q&A articles that are conducted with ...

PMCB - PharmaCyte Biotech Releases Shareholder Update Call Playback Information

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ® , announced today that an audio recording of the company’s shareholder update ca...
Previous 10 Next 10